Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of VER-01 in Healthy Volunteers
NCT04930809Phase 1Completed
- Sponsor
- Vertanical
- Start
- Nov 2021
- Primary completion
- Jul 2022
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of VER-01 in chronic low back pain (CLBP) (7 arms), sponsored by Vertanical. Primary endpoints: Area Under the Curve from Time 0 to Last Measurable Concentration at Day 4, Area Under the Curve from Time 0 to Infinity at Day 4 and 1 more. Started Nov 2021; status: completed.
02
Drugs
VER-01
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT04930809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04930809.